Pharmacogenomics · 2020 · 12 citations · 28 references
MedicineGeneticsPharmacologyHuman GeneticsPharmacogeneticsPharmacogenomicsCardiovascular PharmacogenomicsGenetic RiskGenotype-phenotype CorrelationPharmacogenomic BiomarkersPopulation PharmacogeneticsPopulation PharmacogenomicsAllele FrequencyAncestry-related Pharmacogenetic DifferencesCardiovascular Genetic RiskCyp2c19 PharmacogeneticsCytochrome P450 2C19 GenotypingPharmacogenetic Variant FrequenciesPharmacogenomics Of Cardiovascular DrugsSlco1b1 Genotype
Background: The aim of this study was to determine the prevalence of CYP2C9, VKORC1, CYP2C19, ABCB1, CYP2D6 and SLCO1B1 genes polymorphisms among residents of the Volga region (Chuvash and Mari) and northern Caucasus (Kabardins and Ossetians). Materials & methods: The study involved 845 apparently healthy volunteers of both sexes of the four different ethnic groups living in the Russian Federation: 238 from the Chuvash ethnic group, 206 Mari, 157 Kabardins and 244 Ossetians. Results: Significant differences were identified in allele frequency of CYP2C9, VKORC1, CYP2C19, ABCB1, CYP2D6 and SLCO1B1 genes polymorphisms between the Chuvash and Kabardins, Chuvash and Ossetians, Mari and Kabardians, Mari and Ossetians.
28
SNPStats: a web tool for the analysis of association studies
Xavier Solé, Elisabet Guinó, Joan Valls et al. · Bioinformatics · 2006 · 2K citations · Full text
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
Shufeng Zhou · Clinical Pharmacokinetics · 2009 · 759 citations
Medicine, Genetics, Pharmacology +14